Literature DB >> 9474051

Strategies for physician education in therapeutic drug monitoring.

D W Bates1, S J Soldin, P M Rainey, J N Micelli.   

Abstract

Although therapeutic drug monitoring (TDM) is probably very useful overall, studies suggest that it could be used better. Many drug concentrations appear to have inappropriate indications or suboptimal timing, particularly in the inpatient setting. Undermonitoring is also a concern. Thus, it may be possible to both improve the quality of TDM and reduce the overall costs of care. Here we review approaches for improving the use of TDM and present some illustrative experiences. Specific approaches discussed include use of traditional approaches such as lectures and newsletters, multidisciplinary quality improvement efforts, formal TDM services, and use of the computer as a tool for education and behavior change. Computerized methods appear to hold substantial potential, particularly as more organizations develop better information systems, but other approaches are also effective and are complementary. To be most successful, interventions should consider all stages of the process.

Mesh:

Substances:

Year:  1998        PMID: 9474051

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  11 in total

Review 1.  Review: therapeutic drug monitoring in pediatrics.

Authors:  Offie Porat Soldin; Steven J Soldin
Journal:  Ther Drug Monit       Date:  2002-02       Impact factor: 3.681

2.  Quality of requests for serum digoxin concentrations: experience from an Australian regional health service.

Authors:  Chris Ellington; Nick Grgurinovich; John O Miners; Arduino A Mangoni
Journal:  Br J Clin Pharmacol       Date:  2006-10-30       Impact factor: 4.335

Review 3.  Benchmarking therapeutic drug monitoring software: a review of available computer tools.

Authors:  Aline Fuchs; Chantal Csajka; Yann Thoma; Thierry Buclin; Nicolas Widmer
Journal:  Clin Pharmacokinet       Date:  2013-01       Impact factor: 6.447

4.  Vancomycin administration: the impact of multidisciplinary interventions.

Authors:  R K Crowley; F Fitzpatrick; D Solanki; S FitzGerald; H Humphreys; E G Smyth
Journal:  J Clin Pathol       Date:  2007-02-09       Impact factor: 3.411

5.  Clinical Feasibility of Monitoring Enoxaparin Anti-Xa Concentrations: Are We Getting It Right?

Authors:  Wesley D Kufel; Robert W Seabury; William Darko; Luke A Probst; Christopher D Miller
Journal:  Hosp Pharm       Date:  2017-03

6.  Inappropriate vancomycin therapeutic drug monitoring in hospitalized pediatric patients increases pediatric trauma and hospital costs.

Authors:  Manika Suryadevara; Kelly E Steidl; Luke A Probst; Jana Shaw
Journal:  J Pediatr Pharmacol Ther       Date:  2012-04

7.  Educational intervention to improve appropriate digoxin therapeutic drug monitoring: a quasi-experimental study.

Authors:  Seyma Oncu; Anil Baskurt; Bihter Senturk; Ozgur Aslan; Tuncay Kume; Reyhan Ucku; Ayse Gelal
Journal:  Eur J Hosp Pharm       Date:  2019-10-17

8.  Rapid detection and identification of overdose drugs in saliva by surface-enhanced Raman scattering using fused gold colloids.

Authors:  Stuart Farquharson; Chetan Shende; Atanu Sengupta; Hermes Huang; Frank Inscore
Journal:  Pharmaceutics       Date:  2011-07-13       Impact factor: 6.321

9.  A nationwide utilization survey of therapeutic drug monitoring for five antibiotics in South Korea.

Authors:  Rihwa Choi; Hye In Woo; Hyung-Doo Park; Soo-Youn Lee
Journal:  Infect Drug Resist       Date:  2019-07-18       Impact factor: 4.003

10.  Factors Associated with Good Seizure Control in Patients on Valproic Acid.

Authors:  Mastura Ahmad; Ab Fatah Ab Rahman; Sapiah Sapuan
Journal:  Eurasian J Med       Date:  2020-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.